TargetMol

herbacetin-3,8-diglucopyranoside

Product Code:
 
TAR-TN7076
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TN7076-1mg1mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7076-5mg5mg£340.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7076-1mL1 mL * 10 mM (in DMSO)£442.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7076-10mg10mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7076-25mg25mg£707.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7076-50mg50mg£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
herbacetin-3,8-diglucopyranoside is a natural product.
CAS:
99224-12-1
Formula:
C54H58O34
Molecular Weight:
1251.02
Purity:
0.9953
SMILES:
OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(c(OC(c(cc1)ccc1O)=C1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)c(c(O)c2)C1=O)c2OOC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(c(OC(c(cc1)ccc1O)=C1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)c(c(O)c2)C1=O)c2O

References

Woo Song Lee, et al. Pharmaceutical compositions for prevention and treatment of viral diseases containing rhodiola extracts, fractions, the isolated flavonoid compounds therefrom, derivatives compounds thereof or the pharmaceutically acceptable salts as an active ingredient.WO2009151173A1